NHS REC Applications
|
|
- Ami Reynolds
- 6 years ago
- Views:
Transcription
1 This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document for training and reference purposes but are responsible for regularly checking the JRCO website for more recent versions NHS REC Applications SOP Reference: JRCO/SOP/003 Version Number: Final Version 6.0 Effective Date: 30/11/12 Review by: 29/11/14 Author: Becky Ward, Research Governance Manager Approved by: Gary Roper Date: 30/11/12 Version Date Reason for Change Final v July 2006 Final June 2007 Update Final June 2008 Annual Review Final February 2010 Update and Formation of Joint Research Office Final July 2011 Annual Review Final Nov 2012 Annual Review Final version /11/12 Page 1 of 17
2 Table of Contents 1. Purpose Page 3 2. Introduction 2.1 NHS REC Review 2.2 Alternatives to NHS REC review 3. Procedure 3.1 Complete the online Application Form 3.2 Complete the Applicant s Checklist 3.3 Decide Where to Apply/Book a Review Slot 3.4 Proportionate review (expedited review process for minimal risk/burden/intrusion studies) 3.5 Submission 3.6 Validation 3.7 Site Specific Information (SSI) 3.8 Review/Notification of Decision 3.9 Request for Further Written Information 3.10 After Approval Page 3 Page 3 Page 3 Page 5 Page 5 Page 6 Page 6 Page 9 Page 10 Page 10 Page 10 Page 11 Page References Page Appendix Appendix 1 Integrated Research Application System (IRAS) Content Index Integrated Dataset Page 14 Page 14 Final version /11/12 Page 2 of 17
3 1. PURPOSE This SOP details how to apply for NHS Research Ethics Committee (REC) approval for healthrelated research projects. It provides general information on the NHS REC system and outlines each step that should be completed in the application process. Please note the information within this SOP is only a summary. For more detailed guidance see the Standard Operating Procedures for RECs. SOP should also be used in conjunction with JRCO/SOP/002 Ethics Approval for Health-Related Research. The application form for UK REC review can be obtained via the Integrated Research Application System (IRAS) found at: which combines the ethics application with other regulatory forms such as MHRA applications. The IRAS application form replaces the NRES form. All UK studies must apply through this system. 2. INTRODUCTION 2.1 NHS REC Review NHS RECs will review most research conducted within the NHS. Such research could involve: Clinical Trials of Investigational Medicinal Products NHS patients/service users (including potential participants recruited by their past or present treatment and NHS patients treated under contracts with private sector institutions) Potential participants identified because of their status as relatives/carers of patients and users of the NHS Access to data (except anonymised data see alternatives to NHS REC section below), organs or other bodily material of past and present NHS patients Foetal material and IVF involving NHS patients Recently dead in NHS premises Use of/access to NHS premises or facilities Healthy volunteers, where a drug or device is being tested within the NHS A different ethics application route may be needed if your project involves gene therapy, is a Phase I CTIMP in healthy volunteers outside the NHS and/or only being conducted overseas. This is outlined further throughout this SOP and in JRCO/SOP/002 Ethics Approval for Health-Related Research. 2.2 Alternatives to NHS REC: Non-NHS resources/overseas research If your research involves: Non NHS resources Overseas research Then your project may be eligible for review by the Imperial College Research Ethics Committee (ICREC) For further information please see: or contact Christine Buicke, Research Final version /11/12 Page 3 of 17
4 Governance Coordinator Tel: Studies needing R&D only approval: Following changes (Sept 2011) to the remit of RECs in the UK, the following projects need management permission from host care organisations, but are excluded from REC review: Research involving health or social care services staff, who are recruited by virtue of their professional role (no patient involvement) Studies involving retrospectively collected anonymised data Researchers undertaking the above studies should contact the R&D Trust where they wish to conduct their study. The documents that will need to be submitted for this type of project are: R&D form (in IRAS) available at If you complete the filter questions as normal and only tick NHS/HSC Research and Development offices to Q4, this will create a simplified version of the application form Protocol Participant Information Sheet Consent Form Any other supporting documents you intend to use The JRCO will then assess the study and register it on our database. Please do not start your research until you have confirmation from the JRCO that the study has been registered and are in receipt of the Trust approval letter Tissue Bank Approval: Tissue only studies: For Imperial College studies where the only research being undertaken at Imperial is tissue collection (e.g. collecting biopsies, blood only), ethics approval may be obtained from the Tissue Bank, who have been delegated authority from the REC to approve this type of project. You are advised to contact the Tissue Bank for advice (see contact details in the table in section 3.3). This type of approval can only be considered if tissue collection is the only component of the research being undertaken. If there are other research procedures involved (e.g. questionnaires, scans) then a REC review will be needed. Key characteristics of the NHS REC system are that: All applications must be made by the Chief Investigator (CI) for the study. The CI must be professionally based in the UK. For international studies: o An application must be made to an ethics committee in the UK whether or not the study has a favourable ethical opinion outside the UK, and; o If there is a coordinating investigator outside the UK, a health professional based in the UK must be nominated as CI and take responsibility for the conduct of the research in the UK. The REC must give an opinion on a project within 60 days of receiving a valid application as required in law for CTIMPs and the Research Governance Final version /11/12 Page 4 of 17
5 Framework for all other research in the NHS (unless it is a trial of a medicinal product for somatic cell therapy or the product contains a genetically modified organism, in which case the time limit is 90 days). A single ethical opinion will be given for a project, regardless of the number of sites at which it is to be conducted. A main REC will be responsible for all aspects of the ethical review. The suitability of a research site and investigator taking part in the research will be made by site specific information form (SSI) and forms part of the single ethical opinion. Each research site should have a PI responsible for the management and conduct of research at that site. Participant Identification Centres: If research participants are being identified at another organisation this organisation may be classed as a Participant Identification Centre (PIC). A PIC is an NHS Trust where participants are identified and given information on a research project but no research activity (consent, medical screening, blood tests etc.) is taking place. If research activity is to occur at an NHS Trust it must be identified as research site and complete the site specific assessment process as described in section 3.7 of this SOP. 3. PROCEDURE The procedure for applying for NHS REC approval can be divided into the following steps. More detailed information on each step is given below. 1. Complete the online Application Form 2. Complete the Applicant s Checklist 3. Decide Where to Apply/Book a Review Slot 4. Submit 5. Validation 6. Site Specific Information (SSI) 7. Review/Notification of Decision 8. Request for Further Written Information 9. After Approval 3.1 Complete the Online Application Form (the information in this SOP is based on using version 3.4 of the online form) All applications must be made using the IRAS online application form which can be accessed at you are a first time user, you will need to register for an account online, which is activated immediately. You do not have to complete the application form in one go work can be saved and reloaded for further editing. The form is designed to save you time completing it. When you fill in certain answers, information will automatically populate in other relevant places, and your answers to certain questions will deactivate or activate other sections of the form. As a result, you are never likely to complete every single page the average is around 20 pages long. Final version /11/12 Page 5 of 17
6 The application form is structured as in the table below. question topic see Appendix 1. For a breakdown of each Part Project Filter A B Details Asks a limited number of key questions about the nature of your research. An application form specific to your project will be created from the answers you give. You need to select your answers carefully. Asks for generic information relevant to all research proposals. Certain questions will be deactivated depending on your answers to the project filter. Is divided into several discrete sections, which refer to particular specialist topics. These appear (or disappear) in response to your answers to the project filter. C Asks for a list of sites that the study will be conducted at. We have put together some Top Tips for making valid NHS REC applications, explaining how to avoid some of the more common errors in applying, see applications. More detailed information about using the form is available through the help pages on the IRAS form website Complete the Applicant s Checklist You must also complete the Applicant s Checklist with your IRAS ethics application to ensure that all of the paperwork required to support your application is sent to the REC. You can complete the checklist in hard copy or online through the IRAS form system. A different version of the checklist must be completed depending on the type of research; there is one for CTIMPs and another for any other research in the NHS. The online system automatically generates the relevant checklist depending on your answers to the project filter. You must ensure you have the appropriate copies of any supporting documentation, as outlined in the Applicant s Checklist. 3.3 Decide Where to Apply/Book an Agenda Slot When you finish your application, you need to decide where to apply and book an agenda slot at the next meeting of an appropriate REC. Bookings should either be made direct with a local REC in the NHS domain in which the research is to be conducted via the Central Allocation System (CAS) or via the London Local Allocation System (LLAS) depending on the nature of your project, as in the table below. A domain is the area covered by a NHS Strategic Health Authority. The relevant domain for Imperial College Academic Health Science Centre (AHSC) associated NHS Trusts is North West London and incorporates the following RECs: London - Chelsea Final version /11/12 Page 6 of 17
7 London Fulham London West London London Riverside London - Brent London - Central Contact details for above RECs can be found at Type of Project Student Research - non-ctimp NHS REC Booking Route Book with any REC or via the Local Allocation System (LAS) in the Strategic Health Authority For London Local Allocation System : Tel (9.30 a.m. to 4.30 p.m. weekdays) southenglandlas@nhs.net CTIMP Apply via Central Allocation System (CAS) (to a Type 3 REC) Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Phase 1 CTIMPS in Healthy Volunteers ONLY Directly to an NHS REC or Independent Ethics Committee with Type 1 recognition. CAS can identify the first available agenda slot for NHS RECs in UK CAS Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Recommend booking via CAS but can be booked through LLAS Medical Device LLAS Tel: (9.30 a.m. to 4.30 p.m. weekdays) CAS Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Audit or Service Evaluation Check with Joint Research that this is not considered research. If it is not research, no ethical review required. Involves adults lacking capacity to consent - research falling under the Mental Capacity Act or Adults with Incapacity (Scotland) Act Apply via CAS (to a flagged REC) Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Final version /11/12 Page 7 of 17
8 Any project which involves prisoners Apply via CAS (to a flagged REC) Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Book via the Gene Therapy Advisory Committee (GTAC) Tel: Gene Therapy or Stem Cell Clinical Trials In addition to GTAC approval, any gene therapy study taking place at Imperial College Healthcare NHS Trust should also go through the ICHT Joint Clinical Research Safety Committee (JCRSC) Contact: Sharon Wood, Director of Safety Services, USC Ltd, Tel: Sharon.wood@imperial.nhs.uk ) Recommend booking via CAS but can be booked through LLAS Establishing a Research Tissue Bank LLAS Tel: : (9.30 a.m. to 4.30 p.m. weekdays) CAS Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@northwest.nhs.uk Recommend booking via CAS but can be booked through LLAS Establishing a Research Database LLAS Tel: (9.30 a.m. to 4.30 p.m. weekdays) CAS Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Research funded by US Department of Health and Human Sciences Apply via CAS (to a flagged REC) Tel: (9.30 a.m. to 4 p.m. weekdays). CAS@nhs.net Final version /11/12 Page 8 of 17
9 Research Not listed Above Proportionate Review If your research presents minimal risk, burden or intrusion for the participants, it may be eligible for proportionate review (see 3.4) Apply via LLAS Tel: (9.30 a.m. to 4.30 p.m. weekdays) To submit through the London Local Allocation Service Tel: Research involving tissue only collected at Imperial Research which involves: Healthy volunteers (except tissue and drug trials) Non-NHS Resources Overseas Research Staff only studies or research that involves retrospective data collection of anonymised data Contact Joint Research or Tissue Bank Manager. Tissue Bank Manager contact details: Sarah Chilcott-Burns Tissue Bank Manager Department of Surgery & Cancer Faculty of Medicine Imperial College London Hammersmith Hospital campus Rm G02, Ground floor G Block Du Cane Road London W12 0HS tel: s.chilcott-burns@imperial.ac.uk Apply through Imperial College Research Ethics Committee (ICREC) For further information contact: Christine Buicke (Joint Research Coordinator): c.buicke@imperial.ac.uk Contact Joint Research for R&D management permission: Becky Ward becky.ward@imperial.ac.uk for Hammersmith Hospital, Charing Cross Hospital projects ( ) Lucy Parker lucy.parker@imperial.ac.uk for St Mary s Hospital projects ( ) For further information on what constitutes an NHS domain or research site, please refer to paragraphs and of NRES s Standard Operating Procedures for Research Ethics Committees Proportionate Review The aim with the system of proportionate review is for a project to be reviewed, and a decision letter issued, within 14 working days of receipt of a valid application. However, the project may be referred on to a full committee if necessary (which will extend the timescale to the usual 60 days). For your application to be considered for proportionate review, it should fit one of the following categories: Research using data or tissue that is anonymous to the researcher Final version /11/12 Page 9 of 17
10 Research using existing tissue samples already taken with consent for research Research using extra tissue (e.g. further blood taken at time of routine sampling or tissue taken at clinically directed operation) Questionnaire research or research interview/focus group that does not include highly sensitive areas or where accidental disclosure would not have serious consequences Research surveying the safety or efficacy of established non-drug treatments, involving limited intervention and no change to the patients treatment Research involving children may be considered for proportionate review where it meets the above criteria. For further information, please refer to: Submission Once you have booked an agenda slot with the CAS or a local REC, you should be sent confirmation of your booking by , together with a unique REC reference number and the closing date for your application. You must make sure you add the REC reference number to your online application form at this point; it should be inserted in the header section of Page 1 (along with the name of the NHS REC and the submission date). After this information has been added, you will then need to seek the authorisations for your application (you can request electronic signatures) and proceed to submission. For bookings through the CAS, you will need to submit the application electronically to the REC that you have been allocated within 4 working days of your booking. For local applications, you may be required to submit within 4 working days of your booking or at another specified time before the meeting. For projects booked in for proportionate review, you have 2 days to submit your documents. You also need to send the REC office the following in paper copy by the closing date: Application form, with signatures in ink (or electronic signature) Applicant s Check List All relevant supporting documents, as indicated on the Checklist 3.6 Validation If your application is correct and you have submitted it with all the relevant documents by the closing date, you will be issued a validation letter within 5 working days, acknowledging your submission and confirming it is valid. The letter will also provide details (time and venue) of the REC meeting and invite you to attend. It is recommended that you attend the meeting, in order to answer any questions that the REC may wish to address. If Imperial College AHSC is named as sponsor for your research, the Joint Research (JRCO) will also receive a copy of this letter. 3.7 Site Specific Information (SSI) If your research is multi-site, once you have received the validation letter, you can instruct the PIs at each site to apply for SSI and Research and Development (R&D) approval. Final version /11/12 Page 10 of 17
11 Each PI should complete a SSI and R&D form and submit it to the relevant Research and Development (R&D) department, along with a signed and dated copy of his/her CV. If the research is single-site, then the CI should complete an SSI and R&D form and submit to the local R&D office with a signed and dated copy of his/her CV for review. Following a favourable ethical opinion, the PI should send the R&D office a copy of the REC letter and all supporting documents approved by the REC. Each R&D department will notify the PI whether or not there is any objection to the research on site-specific grounds. If there are no objections, the Trust will issue the PI with a R&D approval letter. Please note that any studies taking place on Imperial College Healthcare NHS Trust (ICHT) premises or recruiting ICHT Trust patients or staff must go through the ICHT Trust R&D process and obtain Trust R&D approval, in addition to ethical approval, before they start. Please see JRCO/SOP/031 Trust approval. If studies are taking place at other sites, permission must be obtained from the R&D department at each site, before any research commences there. 3.8 Ethical Review/Notification of Decision At the REC meeting, the Committee will review the ethics of your research in a completely independent way, free from bias or any conflicts of interest. They will consider such things as: Arrangements for the recruitment of subjects How informed consent will be obtained, including the adequacy of written information for participants Provision for compensation in the event of injury attributable to the research Any insurance or indemnity to cover the liability of an investigator or sponsor The Committee must notify you of their decision within 60 days of receiving your valid application. If you find this has not happened, you can complain to the Centre Manager in the first instance (details can be found on: You can also contact:. Complaints Manager Health Research Authority Skipton House 80 London Road London, SE1 6LH Tel: The REC can reach one of five decisions about your application: Final decision which could be favourable, favourable with conditions or unfavourable Provisional decision with a request for further written information No opinion a referee needs to be consulted Final version /11/12 Page 11 of 17
12 You should receive notification of the decision within 10 working days of the review meeting. If Imperial College AHSC is named as Sponsor for your research, the JRCO will also be notified of the ethical decision. 3.9 Request for Further Written Information The REC may make a provisional decision about your research and ask for further information about specific aspects of the project. Such a request can only be made once and the 60 day clock stops whilst the REC awaits your response. If Imperial College AHSC is sponsor of your study, you should send a copy of your response to the request for information and any supporting documents to the JRCO. If your response is not deemed satisfactory, the committee may ask you to respond again to the same questions (no new issues can be raised) or reject your application. The clock only starts again when a complete response is received. A final decision should then be issued After Approval Once you have received NHS REC approval, you still must not start your research until you have all the relevant regulatory approvals e.g. MHRA, NIGB, internal College approval and R&D approval from the relevant NHS Trust(s). Your research must start within 12 months of the date on which a favourable opinion was given. A study is generally considered to have commenced when the first subject gives written informed consent to participate or, where this does not apply, when any procedures in the protocol are initiated. If your research does not commence within 12 months, a substantial amendment will have to be submitted to the REC (and if it does not start within 24 months, you will have to re-apply). After approval, you will also need to: Apply to the main REC for approval of any substantial amendments to the protocol. For any Imperial AHSC sponsored study, you will need permission from the Joint Research before submitting any amendment. You must also apply to each Trust for R&D approval of any amendment before it is implemented at that site (please see JRCO/SOP/006 Amendments to Healthcare Research and JRCO/SOP/032 Trust Amendments ) Submit safety reports when appropriate (please see JRCO/SOP/001) Apply to the relevant R&D department for SSI of any subsequently enrolled research site Provide an annual progress report to the main REC each year of the project s duration Inform the main REC when the project finishes using the end of study declaration form Please note that if Imperial is sponsoring your study then you must also copy safety reports, annual progress reports and end of study reports to the JRCO. Final version /11/12 Page 12 of 17
13 4. REFERENCES Standard Operating Procedures for Research Ethics Committees (version 5.1), March Medicines for Human Use (Clinical Trials) Regulations 2004 NRES website IRAS form website NHS Health Research Authority website - Final version /11/12 Page 13 of 17
14 5. APPENDIX Appendix 1 IRAS Content Index - Integrated Dataset Part A A1 Title of research A2-1 Student project details A2-2 CI for student project A3 Chief Investigator details A4 Central study co-ordinator details A5-1 Research reference numbers A5-2 Other linked studies or applications A6-1 Lay summary A6-2 Overview of study purpose and design A7 Methodology description A8 Type of CTIMP A9 Phase of CTIMP A10 Principal research question/ objective A11 Secondary research question/objective A12 Scientific justification A13 Summary of design and methodology A14-1 Patient/public involvement A14-2 Consulting patients/public on use of data without consent A15 Sample group or cohort A16 First time in humans? A17 Inclusion/ exclusion criteria A18 Details of non-clinical interventions or procedures A19 Details of clinical interventions or procedures A20 Withholding of clinical interventions or procedures A22 Potential risks and burdens A23 Potential for distress in interviews, questionnaires, or group discussions A24 Potential benefits A25 Arrangements for continued provision of intervention after research finished A26 Potential risks for researchers A27-1 Identification of potential participants Final version /11/12 Page 14 of 17
15 A27-2 Screening personal data A27-3 Methods/resources A27-4 Access to personal data outside the care team A27-5 Consent to access identifiable data A28 A29 Details of recruitment through posters or adverts How and by whom potential participants will be approached A30-1 Informed consent A30-2 Recording consent A30-3 Use of data without consent A31 A32 A33-1 Time to decide on participation Participants involvement in other research Participants with inadequate English language skills or special communication needs A33-2 Welsh language A34 A35 A36 A37 A38 A39 A40 A41 A42 A43 A44 A45 A46 A47 A48 Providing information to participants during the research Loss of capacity to consent during the study Checklist of data processing activities Physical security of data storage Confidentiality of data Separation/encryption of identifiers Access to identifiable data during the study Analysis of data and location Data custodian Retention of identifiable data at end of study Period of data storage Long term arrangements for data storage Financial payments/incentives (participants) Financial payments/incentives (researchers) Conflicts of interest A49-1 Notifying GP or health professional A49-2 Permission to notify A50 A51 A52 A53 A54 Trial registration Dissemination of study results Ensuring the anonymity of published data Informing participants of the study results Scientific critique Final version /11/12 Page 15 of 17
16 A55 Assessment by Expert Advisory Group and Commission on Human Medicine A56 Statistical critique A57 Primary outcome measure A58 Secondary outcome measures A59 Sample size A60 Sample size determination A61 Randomisation A62 Methods of analysis A63 Key collaborators A64-1 Lead sponsor A64-2 Sponsor's contact point A64-4 Legal representative in EEA A65 External funding A66 Subcontractors A67 Previous rejection by a REC A68 Lead R&D contact A69 Duration of study A70 Definition of the end of the study A72 Overview of host organisations A73-1 Identification of participants by other organisations A73-2 NHS participant identification centres (PICs) A73-3 Resources for PICs A74 Monitoring and auditing the conduct of the research A75 DMC and stopping rules A76-1 Insurance/indemnity - management of study A76-2 Insurance/indemnity - design of study A76-3 Insurance/indemnity - conduct of study A77 No fault compensation A78 Intellectual property A79 Level of commercial participation Final version /11/12 Page 16 of 17
17 Part B - Additional information for specific applications B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 Investigational medicinal products Medical devices (populates MHRA Devices forms) Exposure to ionising radiation (populates ARSAC forms) Use of existing human tissue samples Use of new human tissue samples Adults unable to consent for themselves Children Additional information for NIGB (populates NIGB form) Information security measures (populates NIGB form) Additional information for Ministry of Justice (populates MoJ form) Part C List of Research Sites C1 List of research sites NHS participant identification centres Part D - Declarations D1 D2 D3 D4 Chief Investigator Sponsor's representative Academic supervisor Information Guardian (NIGB only) Final version /11/12 Page 17 of 17
Document Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationThe changing regulatory and governance environment. for health research across the UK. a guide for researchers. November 2009 v.1
The changing regulatory and governance environment for health research across the UK a guide for researchers November 2009 v.1 UK Clinical Research Collaboration 20 Park Crescent London W1B 1AL United
More informationLondon - Brent Research Ethics Committee 80 London Road Skipton House London SE1 6LH
London - Brent Research Ethics Committee 80 London Road Skipton House London SE1 6LH Telephone: 020 7972 2554 08 November 2016 Professor Rupert Pearse Professor of Intensive Care Medicine Queen Mary University
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CCRN Portal for the latest version. Version: 5.2 Status: Consultation in
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationGaining NHS Trust R&D Approvals
Version 1.1 Effective date: 1 October 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Reason for change Version 1.1 1 October 2012
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationNRES Committee East of England - Cambridge East The Old Chapel Royal Standard Place Nottingham NG1 6FS
NRES Committee East of England - Cambridge East The Old Chapel Royal Standard Place Nottingham NG1 6FS Telephone: 0115 8839390 26 February 2015 Mr Chris Graham Director of Research and Policy Picker Institute
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES
More informationRD SOP12 Research Passport Honorary Contracts / Letters of Access
RD SOP12 Research Passport Honorary Contracts / Letters of Access Version Number: V2.1 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationThe Principal Investigator Role
The Principal Investigator Role Jo Rodda Consultant in Old Age Psychiatry, NELFT North Thames CRN Dementia Specialty Lead What is a Principal Investigator? The person responsible for the conduct of a research
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationUCL Research Ethics Committee. Application For Ethical Review: Low Risk
LONDON S GLOBAL UNIVERSITY UCL Research Ethics Committee Note to Applicants: It is important for you to include all relevant information about your research in this application form as your ethical approval
More informationResearch Governance Standard Operating Procedures (Including ethical review)
Research Governance Standard Operating Procedures (Including ethical review) SOP Reference: SOP/RGO/03 Version Number: 2.0 Date: May 2018 Effective Date: 8 May 2018 Review by: Authors: Author designation:
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationA step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC.
A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC. 28 June 2018 Summary All project-based research conducted in or through the NHS/HSC in England, Northern Ireland,
More informationNorthern Ireland Hospice Research Governance
Northern Ireland Hospice Research Governance Guidance Note 1 Pre-Application Guidance for Applicants How to Prepare an Application to conduct Research Studies in Northern Ireland Hospice Author: Dr. Dorry
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationThe Alfred Streamlining Ethical Review Guide. Overview Page 1. The Review Schemes - A description the two different schemes Page 2
The Alfred Streamlining Ethical Review Guide This Guide contains: Overview Page 1 The Review Schemes - A description the two different schemes Page 2 What is meant by Reviewing or Accepting? Page 2 Where
More informationDocument Title: Version Control of Study Documents. Document Number: 023
Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible
More informationDocument Title: Recruiting Process. Document Number: 011
Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationM. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Principles of Data Collection and Storage SOP Number: 8 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationCLINICAL RESEARCH POLICY
CLINICAL RESEARCH POLICY Approved by: Date of approval: Originator: Medical Director POLICY STATEMENT Good quality clinical research is important for furthering our understanding of the problems encountered
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationStandard Operating Procedure:
Standard Operating Procedure: Preparation and Submission of Annual Progress Reports for all Research Projects and Development Safety Update Reports SOP Number: SOP-QA-21 Version No: 1 Author: Date: 1-9-15
More informationAirwave Health Monitoring Study Information Leaflet for Health Screening
Airwave Health Monitoring Study Information Leaflet for Health Screening Dear participant, Airwave is a digital radio communications system designed for the Police service in England, Wales and Scotland.
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationMarie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of or the Trial Protocol SOP Number: 037 Version Number: 5.0 Effective Date: 17/6/16 Review Date: 17/6/18 Author: Reviewer: Reviewer
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationResearch Fellowships 2018/19 Sample Application Form
Sample Application Form FOR REFERENCE PURPOSES ONLY All applications must be submitted via our online grants management system: Flexigrant, we do not accept hard copy applications https://imperial.flexigrant.com/
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationABMU R&D Operational Framework
ABMU R&D Operational Framework 2017 ABMU R&D Operational Framework 1 R&D Operational Arrangements University Partnership As a University Health Board, ABMU has signed a Memorandum of Understanding (MOU)
More informationResearch Equipment Grants 2018 Scheme 2018 Guidelines for Applicants Open to members of Translational Cancer Research Centres
Research Equipment Grants 2018 Scheme 2018 Guidelines for Applicants Open to members of Translational Cancer Research Centres Applications close 12 noon 08 March 2018 Contents Definitions 3 Overview 4
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationParticipant Information Sheet Adults
Participant Information Sheet Adults Prediction of Lupus TreAtment response Study (PLANS) Finding factors to help us treat lupus patients better and smarter. We would like to invite you
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 20 Items 22, 23 Item 27 Added item regarding responsibility of providers to submit successfully
More informationNHS RESEARCH PASSPORT POLICY AND PROCEDURE
LEEDS BECKETT UNIVERSITY NHS RESEARCH PASSPORT POLICY AND PROCEDURE www.leedsbeckett.ac.uk/staff 1. Introduction This policy aims to clarify the circumstances in which an NHS Honorary Research Contract
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationNHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF
NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF This guidance relates to all staff employed by NHS Fife (including staff within the Health &
More informationAdvanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016
Advanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016 Anchor Statement To define the skills that a Consultant Obstetrician/ Gynaecologist requires,
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationResearch Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012
Research Policy Author: Caroline Mozley Owner: Sue Holden Publisher: Caroline Mozley Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012 Approved by: Executive Board Date approved:
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationAdult Support and Protection Policy & Procedure
scottish commission for the regulation of care Adult Support and Protection Policy & Procedure Improving care in Scotland adult support and protection policy & procedure Introduction The Adult Support
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationNational Research Ethics Service
National Research Ethics Service NRES Committee North West - Haydock HRA NRES Centre - Manchester 3rd Floor - Barlow House 4 Minshull Street Manchester M1 3DZ 16 May 2014 Telephone: 0161 625 7827 Facsimile:
More informationETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM
ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM Outline Introduction Composition Responsibilities of IEC Responsibilities
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationSignatures. Signature Name Date Vice-Chancellor, University of Birmingham
Memorandum of Understanding on Joint Working for Effective Research Governance between The University of Birmingham (the University ) and University Hospital Birmingham NHS Trust (the Trust ) Issue: Effective
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationCareer Development Fellowships 2018 Guidelines for Applicants. Applications close 12 noon 05 April 2018
Career Development Fellowships 2018 Guidelines for Applicants Applications close 12 noon 05 April 2018 Contents Definitions 3 Overview 4 Career Development Fellowship (CDF) 5 Eligibility 7 Assessment of
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More informationEligibility Criteria for NIHR Clinical Research Network Support
Eligibility Criteria for NIHR Clinical Research Network Support December 2017 Title: Eligibility Criteria for NIHR Clinical Research Network Support Author: Authored by NIHR Clinical Research Network.
More informationNRES Committee Yorkshire & The Humber - Bradford Leeds Jarrow REC Centre Jarrow Business Centre Room 002 Rolling Mill Road Jarrow NE32 3DT
NRES Committee Yorkshire & The Humber - Bradford Leeds Jarrow REC Centre Jarrow Business Centre Room 002 Rolling Mill Road Jarrow NE32 3DT 1 December 2014 Telephone: 0191 428 3565 Professor Robbie Foy
More informationWELLBEING OF WOMEN RESEARCH PROJECT GRANTS 2018 GUIDELINES FOR APPLICANTS
WELLBEING OF WOMEN RESEARCH GRANT APPLICANT GUIDELINES 2018 Amended October 2017 WELLBEING OF WOMEN RESEARCH PROJECT GRANTS 2018 GUIDELINES FOR APPLICANTS TABLE OF CONTENTS About Wellbeing of Women...
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationBy ticking this box, I confirm that I meet the overseas applicant eligibility criteria for the Networking Grants
Global Challenges Research Fund (GCRF) Networking Grants Sample of online application form Page 1: Eligibility criteria - overseas researcher To be eligible as the lead overseas researcher, you must: have
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationRegister No: Status: Public on ratification
Private Patient Policy Type: Policy Register No: 12024 Status: Public on ratification Developed in response to: Service Development Contributes to CQC Outcome number: 4 Consulted With Post/Committee/Group
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationSTANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office
STANDARD OPERATING PROCEDURE SOP 220 Investigation of allegations of Research Fraud and Misconduct Version 1.4 Version date 27.02.2018 Effective date 2.03.2018 Number of pages 8 Review date February 2020
More informationGuidance on use of the Model Agreement for Non-Commercial Research in the Health Service (2008 Version)
Guidance on use of the Model Agreement for Non-Commercial Research in the Health Service (2008 Version) PART A Context and Use of the Model Agreement A1. Background to the development of the Model Agreement
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationPhD Scholarship Guidelines
Contents 1.0 Overview: Arthritis and Osteoporosis Victoria... 1 1.1 Description of the Funding Scheme... 1 2.0 Eligibility... 1 3.0 Level of Funding... 2 4.0 Duration... 2 5.0 General Requirements... 2
More information